Enzolytics Inc (ENZC)

[foxi]

Yours is definitely a more in-depth analysis than most of them!


Here's what I see:

Currently there are 2,797,935,953 outstanding shares. That makes the market cap $382,757,638 ($382 Million) at the current price of $.1368/share.

In a scenario where there are still 2,797,935,953 outstanding shares in 2026, but share price was $5, the market cap would be:

2,797,935,953 * $5/share = 13,989,679,765 or just about $14 Billion dollars.

If:
- ENZC can make 50% of the profit from Enzoimmune Active as revenue,
- The global immunomodulator market projections of $240 Billion collective worth by 2026 hold true,
- Rosetta can corner 1% of that market,
- No expensive lawsuits or other hurdles get in the way,

Then ENZC might be seeing a max of $240B * .01 * .50 = $1.2B in annual revenue (not including royalties) if I did the math right. Without further research, I'm not sure how this would factor into the share price, but it'd be decidedly higher than $0.13/share.

Now throw in Clone-3, any products from ENZC's conserved target sites patents, expansion into the veterinary industry... it starts to add up to some serious potential.